Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-441031
Filing Date
2013-11-14
Accepted
2013-11-14 06:08:52
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d601857d10q.htm 10-Q 619424
2 EX-31.1 d601857dex311.htm EX-31.1 7963
3 EX-31.2 d601857dex312.htm EX-31.2 8002
4 EX-32.1 d601857dex321.htm EX-32.1 3208
5 EX-32.2 d601857dex322.htm EX-32.2 3214
  Complete submission text file 0001193125-13-441031.txt   4052062

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttph-20130930.xml EX-101.INS 443705
7 XBRL TAXONOMY EXTENSION SCHEMA ttph-20130930.xsd EX-101.SCH 36426
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20130930_cal.xml EX-101.CAL 47573
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20130930_def.xml EX-101.DEF 124884
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20130930_lab.xml EX-101.LAB 344313
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20130930_pre.xml EX-101.PRE 245322
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 131216635
SIC: 2834 Pharmaceutical Preparations